Seeking for partners for Horizon Europe health topics
Updated: Nov 29, 2021
NETO Innovation is seeking for partners to put together consortia related to 6 topics from Horizon Europe - Cluster 1.
NETO Innovation is aiming to arrange consortia with partners from startups, SMEs, Research and Technological Centers (RTO), large companies, and universities for mainly 6 topics from Cluster 1 – Health for life science and healthcare applications :
HORIZON-HLTH-2022-DISEASE-06-02-two-stage addressing the next generation of immunotherapies.
HORIZON-HLTH-2022-DISEASE-06-03-two-stage addressing vaccines development.
HORIZON-HLTH-2022-DISEASE-06-04-two-stage addressing the therapies for rare diseases such as genetic diseases, rare cancers, and auto-immune diseases.
HORIZON-HLTH-2022-STAYHLTH-01-04-two-stage addressing artificial intelligence tools to predict, diagnose, monitor, and follow up chronic diseases.
HORIZON-HLTH-2022-STAYHLTH-01-05-two-stage addressing overweight and methods to prevent obesity.
HORIZON-HLTH-2022-TOOL-11-01 addressing the use of biomarkers to efficiently and cost-effectively treat patients.
Main information concerning these topics are shown on the table below.
Are you interested by one or more of the topics above? Contact NETO Innovation team, so we can schedule a meeting and discuss how we can put you together with the right partners to prepare a successful proposal.
Subscribe to our website, so you will receive all our partner search posts directly in your inbox.
Follow us on social medias and keep up to date with our latest news: